Moorhead – The Department of Nutrition, Dietary and Exercise Sciences of Concordia College invites adults from 55 to 70 years to a study examining how drug and lifestyle habits can influence cognitive function.
Directed by Betsy Cogan, a nutritionist dietitian, the study focuses on overweight or obese people, or who are currently taking anti-obeditus drugs such as semaglutide, liraglutide, dulaglutide or exénatide.
Research aims to shed light on the growing use of agonist drugs of the GLP-1 receptor and their possible cognitive advantages in aging adults, said a press release from Concordia.
“It is clear that these types of drugs produce significant weight loss and have several other health benefits that are now shown in the literature; however, it is not clear if such advantages extend to cognitive health,” Cogan said in the press release.
Participants will undergo bodily measures, blood sample and cognitive assessments. They will also carry a system for monitoring activities and will finish a log of food and drinks over three days, according to the press release.
For their time, they will receive personalized health data, including body composition, blood pressure, cholesterol and glucose and detailed food analysis.
Participants can withdraw at any time, depending on the press release.
For more information, contact Betsy Cogan in
or 218-299-3644.
Our editorial room occasionally reports stories under a signature of “staff”. Often, the signature of the “staff” is used during the rewriting of basic information which comes from official sources, such as a press release from the city on a closure of the road, and which require little or no report. Sometimes this signature is used when a news includes many authors or when history is formed by aggregating the news previously reported from various sources. If external sources are used, it is noted in history.